Literature DB >> 12870889

Identification of potential aryl hydrocarbon receptor antagonists in green tea.

C M Palermo1, J I Martin Hernando, S D Dertinger, A S Kende, T A Gasiewicz.   

Abstract

Previous investigations have implicated green tea to exert chemopreventive effects in animal models of chemical carcinogenesis, including polycyclic aryl hydrocarbon-induced cancers. In an effort to understand the compound(s) responsible for this protection, the effects of green tea extracts (GTE) and individual green tea catechins on aryl hydrocarbon receptor (AhR) gene induction were determined. Green tea (GT) was organically extracted and subsequently fractionated by column chromatography. The chemical composition of each fraction was determined by NMR. Several fractions inhibited tetrachlorodibenzo-p-dioxin-induced transcription of a dioxin responsive element-dependent luciferase reporter in stably transfected mouse hepatoma cells in a concentration-dependent manner. To determine the GT component(s) responsible for the observed effects, individual catechins were tested in the luciferase reporter system at concentrations found within the active fractions. Of the catechins tested, epigallocatechingallate (EGCG) and epigallocatechin (EGC) were the most potent antagonists, with IC(50) values of 60 and 100 microM, respectively. Re-creation of the active fractions using commercially available catechins further confirmed the identification of EGCG and EGC as the active AhR antagonists in green tea. These data suggest that EGCG and EGC are capable of altering AhR transcription and are responsible for most, if not all, of the AhR antagonist activity of GTE.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12870889     DOI: 10.1021/tx025672c

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  15 in total

1.  EGCG protects endothelial cells against PCB 126-induced inflammation through inhibition of AhR and induction of Nrf2-regulated genes.

Authors:  Sung Gu Han; Seong-Su Han; Michal Toborek; Bernhard Hennig
Journal:  Toxicol Appl Pharmacol       Date:  2012-04-06       Impact factor: 4.219

Review 2.  Natural product inhibitors of Hsp90: potential leads for drug discovery.

Authors:  M W Amolins; B S J Blagg
Journal:  Mini Rev Med Chem       Date:  2009-02       Impact factor: 3.862

3.  Evidence for a novel anti-apoptotic pathway in human keratinocytes involving the aryl hydrocarbon receptor, E2F1, and checkpoint kinase 1.

Authors:  K Frauenstein; U Sydlik; J Tigges; M Majora; C Wiek; H Hanenberg; J Abel; C Esser; E Fritsche; J Krutmann; T Haarmann-Stemmann
Journal:  Cell Death Differ       Date:  2013-08-02       Impact factor: 15.828

4.  (-)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor.

Authors:  Zhengyu Yin; Ellen C Henry; Thomas A Gasiewicz
Journal:  Biochemistry       Date:  2009-01-20       Impact factor: 3.162

Review 5.  Functions of the aryl hydrocarbon receptor in the skin.

Authors:  Charlotte Esser; Imke Bargen; Heike Weighardt; Thomas Haarmann-Stemmann; Jean Krutmann
Journal:  Semin Immunopathol       Date:  2013-08-16       Impact factor: 9.623

6.  In vitro System for Assessing Dioxin Absorption by Intestinal Epithelial Cells and for Preventing this Absorption by Food Substances.

Authors:  Yayoi Natsume; Hideo Satsu; Mika Hamada; Kazushige Kitamura; Naoto Okamoto; Makoto Shimizu
Journal:  Cytotechnology       Date:  2005-01       Impact factor: 2.058

7.  Carnosol, a constituent of Zyflamend, inhibits aryl hydrocarbon receptor-mediated activation of CYP1A1 and CYP1B1 transcription and mutagenesis.

Authors:  Arash Mohebati; Joseph B Guttenplan; Amit Kochhar; Zhong-Lin Zhao; Wieslawa Kosinska; Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2012-02-28

8.  Mapping multiple endocrine disrupting activities in Virginia rivers using effect-based assays.

Authors:  Diana A Stavreva; Michael Collins; Andrew McGowan; Lyuba Varticovski; Razi Raziuddin; David Owen Brody; Jerry Zhao; Johnna Lee; Riley Kuehn; Elisabeth Dehareng; Nicholas Mazza; Gianluca Pegoraro; Gordon L Hager
Journal:  Sci Total Environ       Date:  2021-02-04       Impact factor: 10.753

9.  Analysis of the effect of the active compound of green tea (EGCG) on the proliferation of peripheral blood mononuclear cells.

Authors:  Farid Saleh; Raj Raghupathy; Sami Asfar; Medhat Oteifa; Noha Al-Saleh
Journal:  BMC Complement Altern Med       Date:  2014-08-30       Impact factor: 3.659

Review 10.  Hsp90 Inhibitors for the Treatment of Chronic Myeloid Leukemia.

Authors:  Kalubai Vari Khajapeer; Rajasekaran Baskaran
Journal:  Leuk Res Treatment       Date:  2015-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.